Previous 10 | Next 10 |
Humana (NYSE:HUM) has priced a public offering of $750M of the company’s 3.700% senior notes, due 2029. Offering is expected to close on March 23, 2022. The company expects net proceeds of approximately $741.1M and intends to use it for general corporate purposes, which may include the...
Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $750 million aggregate principal amount of the company’s 3.700 percent senior notes, due 2029 (the “Senior Notes Offering”). The Senior Notes Offering is ex...
Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...
Glenview Capital Management’s 13F portfolio value decreased from $5.46B to $4.69B this quarter. The number of positions decreased from 59 to 57. They increased Global Payments and Coca Cola Euro Partners while dropping Paramount Global and Takeda. The top three stakes are T...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clover Health Investments (NASDAQ: CLOV ) has finally started to bounce. CLOV stock has climbed about 50% above its lows in recent weeks. Since the stock was over $10 last year, a rally from $2 to just over $3 is hard...
I present my top 15 high-growth dividend stocks to consider during the month of March. The watchlist is off to a poor start this year losing 9.1% through month-end February. Since inception, September 2020, the watchlist is outperforming VIG by 2.90% and SPY by 0.86% on an annuali...
BME is highly concentrated on large caps, but it is yet to recover from the pandemic. It has low dividend yield, thus not suitable for income-seeking investors. Short- and medium-term returns are low when compared with its peers. For further details see: BME: High Concen...
Monthly update of the Dividend Champions List. 139 companies declared higher dividends in the past month, with an average increase of 10.54% over their previous payouts. Fourteen new Contenders, and twelve new Challengers. For further details see: Dividend Champions For ...
HealthEquity continues to grow, and it has demonstrated its ability to generate strong and growing cash flows over time. Long-term, the company will probably do quite well for investors, but this doesn't make it a great prospect. Shares are pricey and are, likely, fairly valued at...
Humana-owned Kindred at Home begins transitioning home health division to new brand; commitment to quality care at home remains strong One year after launching the CenterWell brand to represent Humana’s payer-agnostic healthcare service offerings, Humana Inc. (NYS...
News, Short Squeeze, Breakout and More Instantly...
Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjust...
New collaboration will allow Humana to further modernize its cloud infrastructure and leverage Google Cloud’s Generative AI capabilities to accelerate innovation in healthcare. Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced a new multi-year agre...
Key investments with community partners expand options for historically unsupported populations Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), is investing in community-based organizations throughout Oklahoma to expan...